tiprankstipranks
MediPharm Labs (TSE:LABS)
TSX:LABS
Canadian Market

MediPharm Labs (LABS) Financial Statements

175 Followers

MediPharm Labs Financial Overview

MediPharm Labs's market cap is currently C$27.35M. The company's EPS TTM is C$0; its P/E ratio is -3.31; MediPharm Labs is scheduled to report earnings on March 30, 2026, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Mar 25Dec 23Mar 23Mar 22
Income Statement
Total RevenueC$ 45.12MC$ 41.96MC$ 33.06MC$ 22.12MC$ 21.71M
Gross ProfitC$ 13.97MC$ 12.80MC$ 5.86MC$ -1.91MC$ -15.25M
Operating IncomeC$ -8.41MC$ -10.81MC$ -18.25MC$ -29.53MC$ -48.92M
EBITDAC$ -6.54MC$ -7.52MC$ -10.48MC$ -27.09MC$ -38.55M
Net IncomeC$ -8.27MC$ -10.69MC$ -13.08MC$ -29.98MC$ -54.80M
Balance Sheet
Cash & Short-Term InvestmentsC$ 10.81MC$ 11.69MC$ 17.98MC$ 24.14MC$ 34.11M
Total AssetsC$ 45.74MC$ 53.73MC$ 63.94MC$ 65.50MC$ 92.36M
Total DebtC$ 201.00KC$ 388.00KC$ 2.29MC$ 632.00KC$ 216.00K
Net DebtC$ -10.61MC$ -11.30MC$ -15.69MC$ -23.51MC$ -33.89M
Total LiabilitiesC$ 9.93MC$ 10.55MC$ 10.93MC$ 9.49MC$ 9.21M
Stockholders' EquityC$ 35.81MC$ 43.18MC$ 53.01MC$ 56.01MC$ 83.15M
Cash Flow
Free Cash FlowC$ -5.60MC$ -5.01MC$ -12.81MC$ -16.93MC$ -14.00M
Operating Cash FlowC$ -5.50MC$ -4.86MC$ -12.34MC$ -16.07MC$ -13.21M
Investing Cash FlowC$ 4.62MC$ 413.00KC$ 6.87MC$ 5.16MC$ 35.00K
Financing Cash FlowC$ -18.00KC$ -1.85MC$ -368.00KC$ 796.00KC$ 27.80M
Currency in CAD

MediPharm Labs Earnings and Revenue History

MediPharm Labs Debt to Assets

MediPharm Labs Cash Flow

MediPharm Labs Forecast EPS vs Actual EPS